拓新药业 (301089.SZ)

今开: 最高: 成交量:

昨收: 最低: 成交额:

+ 收藏

利润表(拓新药业)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2024年三季报2024年中报2024年一季报2023年年报2023年三季报2023年中报2023年一季报
上市前/上市后 上市后上市后上市后上市后上市后上市后上市后
报表类型 合并报表合并报表合并报表合并报表合并报表合并报表合并报表
一、营业总收入(元) 325,753,716.96218,756,705.10108,322,506.68835,509,951.28746,127,863.80656,976,189.03551,007,175.69
 营业收入(元) 325,753,716.96218,756,705.10108,322,506.68835,509,951.28746,127,863.80656,976,189.03551,007,175.69
二、营业总成本(元) 349,459,875.73230,768,163.87111,604,696.36517,162,283.47366,447,775.50256,091,187.13145,292,581.58
 营业成本(元) 242,077,660.34165,051,401.3779,986,578.97351,952,513.76225,736,875.62161,447,781.6795,127,708.27
 研发费用(元) 28,913,083.6216,168,269.048,246,051.3451,249,522.2134,942,697.2621,932,676.685,463,699.61
 营业税金及附加(元) 5,189,793.222,983,628.251,277,369.6413,019,674.9111,274,936.239,736,296.087,583,373.87
 销售费用(元) 9,524,506.166,026,921.162,100,833.349,828,891.098,985,971.785,866,581.912,606,320.90
 管理费用(元) 65,788,241.8042,924,862.2420,722,760.0694,474,128.1788,224,590.0259,210,000.2634,717,917.60
 财务费用(元) -2,033,409.41-2,386,918.19-728,896.99-3,362,446.67-2,717,295.41-2,102,149.47-206,438.67
  其中:利息费用(元) --620.52337,069.98285,058.95238,677.70285,058.95
  其中:利息收入(元) 2,264,292.771,817,543.80487,280.893,288,967.15965,427.811,755,084.43965,427.81
三、其他经营收益
 加:公允价值变动收益(元) -463,661.31-544,779.12-704,998.30546,870.44-158,127.86969,161.81-158,127.86
 加:投资收益(元) 2,963,289.621,953,769.651,453,695.626,569,233.696,288,621.533,512,683.421,380,136.61
  其中:对联营企业和合营企业的投资收益(元) ----115.51---
 资产处置收益(元) ---4,909.59----
 资产减值损失(元) ----10,768,156.06-4,150,028.51-3,638,540.29-
 信用减值损失(元) 3,156,184.842,418,933.912,385,995.35-4,485,090.22-7,013,573.11-8,044,783.42-8,576,001.12
 其他收益(元) 10,901,554.507,034,864.212,629,281.7811,473,406.457,249,159.863,936,380.462,830,960.49
四、营业利润(元) -7,148,791.12-1,148,670.122,476,875.18321,683,932.11381,896,140.21397,619,903.88401,191,562.23
 加:营业外收入(元) 148,190.7383,163.1629,957.521,422.951,422.96422.9660.00
 减:营业外支出(元) 3,896,564.18267,749.5354,627.145,151,985.272,282,453.712,036,019.551,686,813.78
五、利润总额(元) -10,897,164.57-1,333,256.492,452,205.56316,533,369.79379,615,109.46395,584,307.29399,504,808.45
 减:所得税费用(元) -8,243,385.44446,066.60383,823.7373,460,635.4166,424,275.9486,051,363.1795,198,578.88
六、净利润(元) -2,653,779.13-1,779,323.092,068,381.83243,072,734.38313,190,833.52309,532,944.12304,306,229.57
(一)按经营持续性分类
  持续经营净利润(元) -2,653,779.13-1,779,323.092,068,381.83243,072,734.38313,190,833.52309,532,944.12304,306,229.57
(二)按所有权归属分类
  归属于母公司股东的净利润(元) -2,653,779.13-1,779,323.092,068,381.83243,072,734.38313,190,833.52309,532,944.12304,306,229.57
 扣除非经常性损益后的净利润(元) -10,341,946.98-7,967,008.09-641,436.44231,970,162.40304,278,128.97304,161,278.88302,531,567.98
七、每股收益
 一、基本每股收益(元) -0.02-0.010.021.932.492.462.42
 二、稀释每股收益(元) -0.02-0.010.021.932.492.462.42
八、其他综合收益(元) ----2,126,356.94---
 归属于母公司股东的其他综合收益(元) ----2,126,356.94---
九、综合收益总额(元) -2,653,779.13-1,779,323.092,068,381.83240,946,377.44313,190,833.52309,532,944.12304,306,229.57
 归属于母公司所有者的综合收益总额(元) -2,653,779.13-1,779,323.092,068,381.83240,946,377.44313,190,833.52309,532,944.12304,306,229.57
公告日期 2024-10-262024-08-242024-04-232024-04-232023-10-252023-08-252023-04-26
审计意见(境内) 标准无保留意见
原始财报文件下载 下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)

前瞻产业研究院